Albany Medical Center Leads Way in Historic Cancer Study
Albany Med Hosts Largest Enrollment Site in US
ALBANY, N.Y., October 18, 2012— Albany Medical Center today became the largest single enrollment site for a landmark study being conducted by the American Cancer Society (ACS) to determine factors that cause cancer.
Officials from Albany Med and ACS last month joined with Albany Mayor Jerry Jennings to urge Capital Region residents to enroll in the “Cancer Prevention Study-3,” being conducted by the ACS.
In three enrollments to be held in Albany over the next three days, more than 1,200 individuals are expected to sign up for the study. More than 689 people turned out Thursday to the first of session held at the Hilton Garden Inn at Albany Medical Center, surpassing the previous record held by the Celebration on the Hill on the National Mall in Washington, D.C., where 576 enrolled in one day.
“Since Albany Medical Center announced its partnership with the American Cancer Society, we have urged our employees and community partners to encourage residents throughout the Capital Region—and beyond— to consider participating in this historic and significant research study,” said James J. Barba, president and chief executive officer of Albany Medical Center.
“I am proud to say that in just a short time, we more than doubled our original goal of 500 participants from the Capital Region, and have enlisted more than 1,200 individuals. This overwhelming response speaks to our collective commitment to improving the health of our region,” Barba said.
“Albany Medical Center’s efforts will have a tremendous impact on future generations and how we are changing the face of cancer. Our work would not be possible without such dedicated partners like Albany Med, whose leadership in this effort has raised the standard for others nationwide to emulate,” said Alpa V. Patel, Ph.D., strategic director of the American Cancer Society’s CPS-3 Study, in Atlanta, GA.
Between now and December 2013, the study seeks to enroll 300,000 adults from various racial and ethnic backgrounds nationwide. This is the third study that the American Cancer Society has undertaken since the 1960s; previous studies have provided breakthrough information about the causes of cancer, such as smoking (1960s) and obesity (1990s).
Enrollment is still open and will take place:
• Friday, Oct. 19; 7am-2pm, Harriman State Campus, Building 8A, New York State Department of Tax and Finance, Albany
• Sunday, Oct. 21: 9am-2pm, Making Strides Against Cancer Walk, Washington Park, Albany
Those eligible to participate in the 20-year study are men and women between the ages of 30 and 65 who have never been diagnosed with cancer, according to the American Cancer Society.
Enrolling in the study involves several simple steps: signing an informed consent form; completing a comprehensive survey that includes information on lifestyle, behavioral and other factors related to health; taking a waist measurement; and giving a small blood sample. Once enrolled, the American Cancer Society will send periodic follow-up surveys to update its information, as well as annual newsletters with study updates and results. Prior registration for enrollment is suggested; to schedule an appointment visit http://www.cps3albany.org
Researchers in the American Cancer Society's Epidemiology Research Program will use data from CPS-3 to build on evidence from a series of American Cancer Society studies that began in the 1950s and collectively have involved millions of volunteer participants. The Hammond-Horn Study of 1954 and previous Cancer Prevention Studies (CPS-I and CPS-II) have played a major role in understanding cancer prevention and risk, and have contributed significantly to the scientific basis and development of public health guidelines and recommendations.
Those studies confirmed the link between cigarette smoking and lung cancer, demonstrated the link between larger waist size and increased death rates from cancer and other causes, and showed the considerable impact of air pollution on heart and lung conditions. A second study, CPS-II began in 1982 and is ongoing, but changes in lifestyle and in the understanding of cancer in the three decades since its launch make it important to begin a new study, CPS-3.
About the American Cancer Society
The American Cancer Society combines an unyielding passion with nearly a century of experience to save lives and end suffering from cancer. As a global grassroots force of more than three million volunteers, we fight for every birthday threatened by every cancer in every community. We save lives by helping people stay well by preventing cancer or detecting it early; helping people get well by being there for them during and after a cancer diagnosis; by finding cures through investment in groundbreaking discovery; and by fighting back by rallying lawmakers to pass laws to defeat cancer and by rallying communities worldwide to join the fight. As the nation’s largest non-governmental investor in cancer research, contributing more than $3.4 billion, we turn what we know about cancer into what we do. As a result, more than 11 million people in America who have had cancer and countless more who have avoided it will be celebrating birthdays this year. To learn more about us or to get help, call us any time, day or night, at 1-800-227-2345 or visit cancer.org.
About Albany Medical Center
Albany Medical Center, northeastern New York’s only academic health sciences center, is one of the largest private employers in the Capital Region. It incorporates the 651-bed Albany Medical Center Hospital, which offers the widest range of medical and surgical services in the region, and the Albany Medical College, which trains the next generation of doctors, scientists and other healthcare professionals, and also includes a biomedical research enterprise and the region’s largest physicians practice with 350 doctors. Albany Medical Center works with dozens of community partners to improve the region’s health and quality of life. For more information: www.amc.edu or www.facebook.com/albanymedicalcenter.
Statistical information presented in press releases may no longer be valid.